CRISPR and CAS Gene Technology Market Analysis

Application (Biomedical, Agricultural, Industrial, Biological Research)

The market is also segmented and analyzed for demand and supply by application into biomedical, agricultural, industrial, biological research, and others. Amongst these segments, the biomedical segment is expected to garner a significant share of around 32% in the year 2037. The CRISPR/dCas9 systems are used in the biological and biomedical fields for gene therapy, genome screening, genome editing, live-cell imaging, and cancer study. The increasing use in the detection of the presence of viral infections such as Zika virus, dengue virus, influenza A H7H9, and hepatitis is estimated to drive the market segment growth during the forecast period as per the market analysis. The Zika virus transmitted to more than 40,000 persons in 2022 during epidemiological weeks 1 and 2 in regions of America that included 15 of 52 countries and territories.

The global CRISPR and CAS gene technology market is segmented and analyzed for demand and supply by application into biomedical, agricultural, industrial, biological research, and others. Out of these segments, the agricultural segment is estimated to gain the largest market share of about 23% in the year 2037. The growth of the segment can be attributed to the increasing applications in agriculture to improve quantity and quality of yield. The growing demand for pest-resistant and climate-adaptable crops to prevent food scarcity in low-income countries is estimated to drive the market segment growth. The use of CRISPR and CAS gene technology in agricultural crops helps to enhance the plant yield and increase the resistance to diseases, and herbicides, and accelerate domestication. The increasing gene manipulation of plants to create a plant with beneficial traits and develop a novel and more sustainable crop plant for agricultural systems.

Our in-depth analysis of the global market includes the following segments: